- Bone Marrow Transplant Research
- Botox Research And News
- Complementary Therapies
- Cognition and Cognitive Issues Research
- Diet
- Drugs
- » Aimspro (Goats Serum)
- »» Aimspro Latest News
- »» Aimspro - Published Research Papers
- »» Aimspro - Oxford Optic Neuritis Trial
- » Ampyra (Fampyra)
- » ATX-MS-1467
- » Azathioprine
- » BG-12
- » BHT-3009
- » Cannabis And Cannabinoid Research
- » CHR-1103
- » Cladribine
- » Cyclophosphamide
- » Cyrevia
- » Disease Modifying Drugs
- » Genetically Modified Drugs And Components
- » Gilenya® (fingolimod)
- » Laquinimod
- » Lemtrada (alemtuzumab)
- » Low Dose Naltrexone - Latest News
- » Masitinib
- » MBP8298
- » Minocycline
- » Mitoxantrone and Copaxone Combination Therapy
- » MN-166 (Ibudilast)
- » Modafinil
- » NeuroVax
- » Novantrone (Mitoxantrone)
- » PEGylated interferon beta
- » Prokarin
- » Pycnogenol
- » Rituximab (Rituxan)
- » RPI-78M
- » RTL-1000
- » Sativex®
- » Statins
- » Teriflunomide (Aubagio™)
- » Trimesta (Oral Estriol)
- » Tovaxin
- » Viagra (sildenafil)
- » Zenapax (daclizumab)
- » Further Possible MS Drugs and Treatments
- » Possible Drugs For The Treatment Of MS Symptoms
- Endo-parasites & 'Helpful' Organisms
- Environmental Factors And MS Research
- Ethnic Groups and MS Research
- Exercise
- Familial Risk of Multiple Sclerosis Research
- General Health
- General Research Articles
- General Research News
- Hyperbaric Oxygen Therapy Research
- Lightning Process® And Multiple Sclerosis Research
- Mercury Amalgam Fillings Research
- MS and Genetics Research
- MS Knowledge
- Myelin Research
- Neuropsychiatric and Psychological Research
- New Discoveries
- Optical Assessments and MS Research
- Other Conditions Research
- Paediatric Multiple Sclerosis Research
- Pain Research
- Pregnancy And MS Research
- Quality Of Life Research
- Sex
- Stem Cell Research & Treatment
- Vaccinations & MS Research
- Vitamin B12 Research
- Vitamin D Research & News
You are here : Home »
MS Research News
»
Drugs
»
Aimspro (Goats Serum)
Aimspro (Goats Serum)
|
Aimspro is available now , on the Specials Named Patient Basis , which is when a doctor writes a prescription for the UNLICENSED medication and the patient covers the cost. Aimspro News Published Scientific Papers on Aimspro The Oxford Optic Neuritis Trial Daval International © Multiple Sclerosis Resource Centre (MSRC)
|
| Did you find this information useful? Would you like to comment on this page? Let us know what you think! We welcome all comments and feedback on any aspect of our website - please click here to contact us. |